Image Image Image Image Image Image Image Image Image Image
Access
Up

Up

kestrel_horizontal

· 03/10/2018

Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema

EMD_OCT negre

· 03/10/2018

Clinical trial THR-317-002: Efficacy and safety of THR-317 with ranibizumab in the treatment of diabetic macular oedema

Multicolor

· 01/10/2018

Clinical Trial OAKS and DERBY: Efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD

STARGARDT_BN

· 10/05/2018

Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease

Foto Proxima A

· 31/03/2016

Proxima A: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29633)

FOTO Proxima B

· 31/03/2016

Proxima B: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29639)

DMAE (RTH258)

· 21/09/2015

HARRIER: Clinical trial on patients with choroidal neovascularisation secondary to AMD

AG_assaigCHROMA

· 29/01/2015

CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Injeccions

· 19/12/2014

FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration

Lite 1

· 21/12/2014

LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye

Foto2

· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

DMAE atrofica

· 19/03/2014Recruiting

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD

Foto4_def

· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD

Foto44_3

· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  

Foto49_3

· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

Last modified: 10 December, 2018 - 16:20